Chemical Compound
(S)-[2-Chloro-4- fluoro-5-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-(6- methoxy- pyridazin-3-yl)- methanol1H NMR (500 MHz, DMSO-d6) ppm = 9.12 (s,1H), 7.91 (d, J = 7.7, 1H), 7.69 (d, J = 9.2, 1H),7.66 (d, J = 9.5, 1H), 7.61-7.52 (m, 2H), 7.24-7.19 (m, 2H), 6.61 (d, J = 5.0, 1H), 6.23 (d,J = 4.9, 1H), 4.00 (s, 3H), 3.81-3.75 (m, 4H),3.48-3.43 (m, 4H)
CAS Registry Number
1637542-33-6
Primary record
(S)-[2-Chloro-4- fluoro-5-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-(6- methoxy- pyridazin-3-yl)- methanol1H NMR (500 MHz, DMSO-d6) ppm = 9.12 (s,1H), 7.91 (d, J = 7.7, 1H), 7.69 (d, J = 9.2, 1H),7.66 (d, J = 9.5, 1H), 7.61-7.52 (m, 2H), 7.24-7.19 (m, 2H), 6.61 (d, J = 5.0, 1H), 6.23 (d,J = 4.9, 1H), 4.00 (s, 3H), 3.81-3.75 (m, 4H),3.48-3.43 (m, 4H)
- 库存
- 6,778 克
- 纯度
- 98.1 %
- CAS
- 1637542-33-6
化合物标识与属性
- CAS
- 1637542-33-6
- PubChem CID
- 86292849
- SMILES
- COC1=NN=C(C=C1)[C@H](C2=C(C=C(C(=C2)C3=NC=NC4=C3C=CC(=C4)N5CCOCC5)F)Cl)O
- Canonical SMILES
- COc1ccc([C@@H](O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1
名称与同义词
- nedisertib
- peposertib
- peposertibum
- Nedisertib [INN]
- Cefdinir Impurity25
- M-3814(nedisertib)
- 1637542-33-6
- MSC2490484A
- M3814
- PEPOSERTIB [INN]
- RefChem:171540
- nedisertib (deleted INN)
- GN429E725A
- PEPOSERTIB [WHO-DD]
- MSC-2490484A
- UNII-GN429E725A
- M-3814
- GTPL9766
- orb2279863
- CHEMBL4297629
- SCHEMBL16235559
- SCHEMBL29417846
- SCHEMBL29538639
- SCHEMBL30482760
- MSC 2490484A
- BDBM315715
- EX-A1679
- NSC802822
- NSC816960
- US10172859, Example 136
- EBC-515469
- MSC 2490484A [WHO-DD]
- NSC-802822
- NSC-816960
- DA-65178
- example 136 [WO2014183850]
- TS-10640
- HY-101570
- CS-0021723
- J3.793.564F
- (S)-(2-chloro-4-fluoro-5-(7-morpholinoquinazolin-4-yl)phenyl)(6-methoxypyridazin-3-yl)methanol
- M 3814
- A948525
- (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol
- (~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol
- 3-Pyridazinemethanol, alpha-(2-chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-
- (S)-(2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl)-(6-methoxypyridazin-3-yl)methanol
- (S)-[2-Chloro-4- fluoro-5-(7- morpholin-4-yl- quinazolin-4-yl)- phenyl]-(6- methoxy- pyridazin-3-yl)- methanol1H NMR (500 MHz, DMSO-d6) ppm = 9.12 (s,1H), 7.91 (d, J = 7.7, 1H), 7.69 (d, J = 9.2, 1H),7.66 (d, J = 9.5, 1H), 7.61-7.52 (m, 2H), 7.24-7.19 (m, 2H), 6.61 (d, J = 5.0, 1H), 6.23 (d,J = 4.9, 1H), 4.00 (s, 3H), 3.81-3.75 (m, 4H),3.48-3.43 (m, 4H)
- (S)-{2-chloro-4-fluoro-5-[7-(morpholin-4-yl)quinazolin-4-yl]phenyl}(6-methoxypyridazin-3-yl)methanol
- 1IX
- 3-PYRIDAZINEMETHANOL, .ALPHA.-(2-CHLORO-4-FLUORO-5-(7-(4-MORPHOLINYL)-4-QUINAZOLINYL)PHENYL)-6-METHOXY-, (.ALPHA.S)-
- 3-Pyridazinemethanol, |A-[2-chloro-4-fluoro-5-[7-(4-morpholinyl)-4-quinazolinyl]phenyl]-6-methoxy-, (|AS)-